Investigating the Dubousset Functional Test for Multiple Sclerosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the validity and reliability of the Dubousset Functional Test (DFT) in individuals diagnosed with Multiple Sclerosis (MS). Participants will undergo a series of balance assessments, including the DFT and other established mobility tests, to determine their performance and stability. The study will utilize a test-retest design, with assessments conducted by the same physiotherapist to ensure consistency. Data on socio-demographic and clinical characteristics will also be collected to provide a comprehensive profile of the participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being diagnosed with MS,
* Over 18 years of age and under 65 years of age,
* To be able to balance independently in standing position.
* EDSS score of 3.5 and below
* At the appropriate cognitive level to adapt to the tests to be performed in the study,
* Completed primary school level,

Exclusion Criteria:

* Relapse within the last 30 days,
* Loss of balance or gait disturbance affected by a condition other than MS,
* Being pregnant for female individuals,
* An attack of optic neuritis in the last month
* Individuals who are unable to perform the task due to sensory, cognitive or other problems will be excluded.

Where it's running

• Erciyes University
  Kayseri, Kayseri, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: betül erciyes university
• Email: bonerdiir@gmail.com
• Phone: +905061514082

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using short selfie videos to measure walking and speech changes in people with MS

  This project will test whether short selfie videos taken by people with MS can reliably show walking and speech changes similar to what clinicians see in person.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07222618

• At-home full-body stimulation suit to manage spasticity and ataxia in MS

  This project will try whether wearing a full-body electrical stimulation suit for six weeks helps people with MS who have spasticity or ataxia reduce symptoms and improve daily functioning.

  Recruiting at 2 sites Universitair Ziekenhuis Brussel · Steenokkerzeel and 1 other locations · NCT07202195

• Transcranial alternating current stimulation for cognitive problems in inflammatory demyelinating CNS disorders

  This trial will try transcranial alternating current stimulation to see if it improves thinking and memory in adults with multiple sclerosis and related inflammatory demyelinating central nervous system disorders.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07087873

• Imaging demyelination with [18F]3F4AP PET

  This test uses a PET tracer called [18F]3F4AP in adults with demyelinating conditions and in healthy volunteers to see how the tracer moves through the body.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT06999434

• Psilocybin therapy for depression and existential distress in people with COPD, ALS, MS, or atypical Parkinson disease

  This trial will test whether psilocybin therapy can reduce depression and psychological distress in adults with COPD, ALS, MS, or atypical Parkinson disease who have at least six months expected life.

  Recruiting at 4 sites Phase 2 University Medical Center Groningen · Prague and 3 other locations · NCT06782724

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.